Peterson Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$10.5K Buy
+363
New +$10.6K 0.04% 203
2023
Q1
Sell
-22,782
Closed -$1.17M 60
2022
Q4
$1.17M Sell
22,782
-12,304
-35% -$590K 1.54% 25
2022
Q3
$1.54M Buy
35,086
+2,494
+8% +$121K 1.49% 24
2022
Q2
$1.71M Buy
32,592
+1,919
+6% +$97.8K 1.61% 25
2022
Q1
$1.59M Sell
30,673
-1,389
-4% -$72.1K 1.32% 33
2021
Q4
$1.89M Buy
+32,062
New +$1.59M 1.54% 23

Other funds holding PFE

Peterson Financial Group's PFE Position: Q3 2024 in Review

Peterson Financial Group opened a new position in Pfizer (PFE) in Q3 2024: 363 shares worth $10.5K. The stake represents 0.04% of the portfolio and ranks #203 among its holdings. This is a return to the name: Peterson Financial Group previously reported a position in PFE as recently as Q4 2022.

Peterson Financial Group first reported a position in PFE in Q4 2021 and has held it in 6 quarters since. The position peaked at $1.89M in Q4 2021. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Peterson Financial Group held 363 shares of Pfizer worth $10.5K as of Q3 2024.
  • Pfizer was a new Peterson Financial Group position in Q3 2024.
  • Pfizer made up 0.04% of Peterson Financial Group's portfolio in Q3 2024, its #203 holding.
  • Peterson Financial Group first reported a position in Pfizer in Q4 2021 and has held it in 6 quarters since.
  • Peterson Financial Group's Pfizer position peaked at $1.89M in Q4 2021.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Peterson Financial Group's 13F filing for Q3 2024, filed 6 Nov 2024.